Prescription ID | TCMF3374 |
Pinyin Name | Fu Fang Da Qing Ye He Ji |
Chinese Name | 复方大青叶合剂 |
English Name | Fu Fang Da Qing Ye Recipe |
Function Description | 感冒, 痄腮, 胁痛, 黄疸 |
Indications | Hypochondrium pain disorder, Jaundice disorder, Common cold disorder, Viral hepatitis, Jaundice, Mumps, Influenza |
Disease ICD-11 Category |
SA00 [Hypochondrium pain disorder (TM1), 胁痛 (TM1)
]; SA01 [Jaundice disorder (TM1), 黄疸 (TM1) ]; SA60 [Common cold disorder (TM1), 感冒 (TM1) ]; 1E5Z [Viral hepatitis, unspecified, 病毒性肝炎,未特指的 ]; ME10.1 [Unspecified jaundice, 未特指的黄疸 ]; 1D80 [Mumps, 腮腺炎 ]; 1E32 [Influenza, virus not identified, 季节性流行性感冒,病毒尚未鉴定 ]; |
Human Tissues Associated with Indication | Lung, Liver, Blood |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH381 | Isatis indigotica | 大青叶 | TCMH381 | KJ765825 |
TCMH1127 | Lonicera japonica | 金银花 | TCMH1127 | ITSAI3881-14 |
TCMH1665 | Notopterygium incisum | 羌活 | TCMH1665 | JF755946 |
TCMH1708 | Polygonum bistorta | 拳参 | TCMH1708 | GQ434560 |
TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT187 | AR | Androgen Receptor | Nuclear receptor | P10275 |
TCMT188 | DHFR | Dihydrofolate reductase | Oxidoreductase | P00374 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT265 | GSK3B | Glycogen synthase kinase-3 beta | Kinase | P49841 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT336 | IDO1 | Indoleamine 2,3-dioxygenase | Oxidoreductase | P14902 |
TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT575 | PLA2G2A | Phospholipase A2 group IIA | Hydrolase | P14555 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT689 | TGM2 | Protein-glutamine gamma-glutamyltransferase | Transferase | P21980 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT783 | NR3C2 | Mineralocorticoid receptor | Nuclear receptor | P08235 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT904 | PGR | Progesterone receptor | Nuclear receptor | P06401 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1183 | Candida albicans SC5314 |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1206 | Influenza A virus (A/PR/8/34(H1N1)) |
TCMT1208 | Escherichia coli K12 |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1241 | Human rhinovirus 14 |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1285 | Human coxsackievirus B3 |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1333 | Human rhinovirus 1A |
TCMT1346 | Helicobacter pylori |
TCMT1347 | Human rhinovirus 16 |
TCMT1348 | Human rhinovirus 2 |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1393 | Vibrio sp. |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.0901 |
[BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.0901 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, GSK3B, HSD11B2, HSD17B2, HTR1B, HTR5A, IDO1, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC, TYR | 14.458 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, IGF1R, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC, TYR | 14.3427 |
[BP] GO:0033993 | response to lipid | ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, IDO1, NR3C1, PTGS2, RORC, SRC, TYR | 13.2417 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HTR1B, HTR5A, IDO1, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RORC, SRC, TYR | 12.826 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, XDH | 12.5032 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, NR3C1, PTGS2, RORC, SRC, TYR | 11.1706 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PTGS1, PTGS2 | 10.4238 |
[BP] GO:0097756 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 8.97941 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PTGS2, RORC, SRC, TYR | 8.95891 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PTGS1, PTGS2, RORC, SRC, TYR | 8.95891 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH | 8.51687 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PGR, PIM1, PTGS1, PTGS2, SRC, XDH | 8.41764 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 8.37453 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 8.3463 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, NR3C1, PTGS2, SRC | 8.20896 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, HTR2B, HTR2C, IDO1, PIK3CA, PIM1, PTGS1, PTGS2, TYR, XDH | 8.02938 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, GSK3B, HSD11B2, HTR1B, HTR5A, IGF1R, MMP2, NR3C1, PTGS2, SRC | 7.89305 |
[BP] GO:0007187 | None | ADORA1, CNR1, CNR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 7.49506 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.33446 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, NR3C1, PTGS2, SRC | 7.11803 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 7.09992 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GSK3B, HTR1B, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RORC, SRC | 7.09651 |
[BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 7.09651 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, HTR1B, IGF1R, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC | 7.0567 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 6.8948 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GSK3B, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 6.86932 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C | 6.8313 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FLT3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, XDH | 6.77598 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, TYR | 6.72645 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, APP, CA2, CNR1, CNR2, ESR1, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC | 6.69529 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 6.67203 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, FABP4, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 6.60614 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.59711 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 6.55036 |
[BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 6.49428 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 6.45336 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC | 6.45336 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.34383 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GSK3B, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SRC | 6.33833 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GSK3B, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 6.32991 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, GSK3B, HTR2B, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 6.29624 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, CNR1, CNR2, HTR1B | 6.27646 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 6.19346 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, XDH | 6.16799 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 6.15135 |
[BP] GO:0050795 | None | ADORA1, CNR1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 5.9982 |
[BP] GO:0006730 | one-carbon metabolic process | CA12, CA2, CA4, CA7, CA9, DHFR | 5.99483 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 5.9339 |
[BP] GO:0003018 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 5.85524 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 5.82993 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GSK3B, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SRC | 5.81836 |
[BP] GO:0048545 | response to steroid hormone | ALPL, AR, BCL2, CA2, FLT3, HSD11B2, HTR1B, NR3C1, PTGS2, SRC | 5.75177 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GSK3B, HTR2B, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, SRC | 5.68773 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.58911 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC | 5.56593 |
[BP] GO:0007193 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 5.5462 |
[BP] GO:0015701 | bicarbonate transport | CA12, CA14, CA2, CA4, CA7, CA9 | 5.52983 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, AR, BCL2, CSNK2A1, ESR1, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2 | 5.50877 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CNR1, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC | 5.47047 |
[BP] GO:0097746 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.42482 |
[BP] GO:0035296 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.42482 |
[BP] GO:0071073 | None | FABP3, HTR2A, HTR2B, HTR2C | 5.33241 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HTR1B, HTR1D, KDR, SRC | 5.3323 |
[BP] GO:0050880 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.23939 |
[BP] GO:0035150 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.21819 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FLT3, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, RORC, SRC | 5.03867 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, HTR1B, IGF1R, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC | 5.03735 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.03735 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CB, PTGS2, SRC | 5.03735 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SRC | 5.03399 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC | 4.9825 |
[BP] GO:0003013 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 4.96509 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FLT3, GSK3B, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PGR, PIK3CA, PIM1, PTGS2, RORC, SRC, TYR | 4.96086 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, HTR2A, HTR2B, HTR2C, KDR, SRC | 4.91894 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AR, AXL, CYP1B1, ESR1, GSK3B, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC | 4.89494 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PTGS2, RORC, SRC | 4.85828 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, HSD11B2, HTR1B, IGF1R, MMP2, PTGS2, SRC, TYR | 4.8543 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.84987 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.84299 |
[BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 4.79527 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.79384 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, HTR1B, NR3C1, PTGS2, SRC | 4.78902 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.78902 |
[BP] GO:0007188 | None | ADORA1, CNR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 4.77103 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, CNR2, HTR1B, HTR2A, PTGS2 | 4.68172 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 4.65386 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, HTR1B, HTR2A, PTGS2 | 4.65386 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, HTR1B, HTR2A, PTGS2 | 4.65386 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, GSK3B, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PTGS2, RORC, SRC, XDH | 4.64838 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, GSK3B, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIM1, PTGS2, RORC, SRC, XDH | 4.55655 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.50955 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP1, MMP2, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 4.5004 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, HSD11B2, HTR1B, IGF1R, MMP2, PTGS2, SRC, TYR | 4.48194 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB | 4.47633 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, APP, AR, BCL2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.46723 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC | 4.41379 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, HTR1A, TYR | 4.36908 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, AR, FLT3, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, SRC, XDH | 4.36331 |
[BP] GO:0071071 | None | FABP3, HTR2A, HTR2B, HTR2C | 4.35712 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, AR, BCL2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.34042 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, APP, AR, BCL2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.34042 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PTGS2, SRC | 4.32672 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, APP, AR, BCL2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.24577 |
[BP] GO:0007154 | None | ADORA1, AR, AXL, BCL2, CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR, PTGS2 | 4.21451 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | AR, ESR1, NR3C1, NR3C2, PGR, RORC, SRC | 4.18098 |
[BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 4.17872 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, APP, AR, BCL2, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.13197 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC | 4.11113 |
[BP] GO:0008283 | cell proliferation | ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TYR | 4.09733 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, AR, BCL2, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 4.08304 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2, SRC | 4.01857 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, CNR1, HTR1B, HTR2A, MMP9, PTGS2 | 3.96491 |
[BP] GO:0048513 | animal organ development | ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, SRC, TYR | 3.93951 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, ESR1, GSK3B, HTR7, PGR, RORC, SRC | 3.93662 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DHFR, FLT3, GSK3B, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 3.91766 |
[BP] GO:0032229 | None | ADORA1, CNR2, HTR1B | 3.90975 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AR, AXL, BCL2, CNR1, CYP19A1, CYP1A1, ESR1, HSD11B2, HSD17B2, IDO1, MMP2, MMP9, PGR, PTGS2, SRC | 3.82403 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PTGS1, PTGS2 | 3.80102 |
[BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2, SRC | 3.80102 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH | 3.78793 |
[BP] GO:0099536 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.77272 |
[BP] GO:0099537 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.77272 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, APP, AR, BCL2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.7376 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, MMP9, PIK3CB, PTGS2, SRC | 3.71379 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2, SRC, TYR | 3.71379 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DHFR, ESR1, FABP4, GSK3B, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PTGS2, RORC, SRC, XDH | 3.71042 |
[BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.70348 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, APP, AR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, PIK3CB, SRC, XDH | 3.70348 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.70348 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B2, HTR1A, HTR2C, IDO1, MMP2, MMP9, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC | 3.63119 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DHFR, FLT3, GSK3B, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 3.63119 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 3.5739 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, CNR1, HTR1B, HTR2A, PTGS2 | 3.55568 |
[BP] GO:0007267 | None | ADORA1, AR, CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR | 3.55459 |
[BP] GO:0009755 | hormone-mediated signaling pathway | AR, ESR1, NR3C1, NR3C2, PGR, RORC, SRC | 3.54403 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PTGS2, SRC, TYR | 3.53676 |
[BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.49958 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 3.45285 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, APP, AR, BCL2, CSNK2A1, ESR1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.43376 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PTGS2, SRC | 3.43214 |
[BP] GO:0030522 | intracellular receptor signaling pathway | AR, ESR1, NR3C1, PGR, PIM1, RORC, SRC | 3.43214 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DHFR, ESR1, FABP4, FLT3, GSK3B, HTR2A, HTR2B, IGF1R, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.42842 |
[BP] GO:0046889 | None | FABP3, HTR2A, HTR2B, HTR2C, PTGS2 | 3.41373 |
[BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.41373 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC | 3.40839 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC | 3.36488 |
[BP] GO:0035265 | organ growth | AR, BCL2, CYP19A1, ESR1 | 3.3593 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.32734 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, APP, AR, BCL2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.28651 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, APP, AR, BCL2, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.26034 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.24587 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, ESR1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PTGS2, RORC, SRC, XDH | 3.23046 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CSNK2A1, FLT3, GSK3B, HTR2B, IGF1R, KDR, MET, PIK3CA, PIM1, SRC | 3.23046 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, XDH | 3.23046 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APP, AR, ESR1, FLT3, GSK3B, HTR1B, IGF1R, MMP2, NR3C1, PTGS2, SRC | 3.23046 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 3.23046 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, AR, BCL2, ESR1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 3.19977 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 3.19551 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.19036 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DHFR, ESR1, FABP3, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PTGS2, RORC, SRC, XDH | 3.18036 |
[BP] GO:0023052 | None | ADORA1, AR, CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR | 3.14613 |
[BP] GO:0090066 | None | ADORA1, ALOX15, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.14613 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, SRC | 3.14613 |
[BP] GO:0060736 | prostate gland growth | AR, CYP19A1, ESR1 | 3.14119 |
[BP] GO:0019371 | None | CBR1, PTGS1, PTGS2 | 3.14119 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, HTR1B, KDR, NR3C1, PTGS2, SRC | 3.10413 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, MMP2, MMP9, PTGS2 | 3.09949 |
[BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 3.0942 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, PTGS1, PTGS2 | 3.09281 |
[BP] GO:0030518 | intracellular steroid hormone receptor signaling pathway | AR, ESR1, NR3C1, PGR, SRC | 3.05069 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, GSK3B, MET, MMP9, SRC | 3.05069 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, PTGS1, PTGS2 | 3.04223 |
[BP] GO:0007268 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.01118 |
[BP] GO:0098916 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.01118 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, AR, BCL2, CNR2, ESR1, GSK3B, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, XDH | 2.98622 |
[BP] GO:0043269 | regulation of ion transport | ADORA1, APP, BCL2, CA2, CA7, CNR1, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 | 2.98418 |
[BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, FLT3, HSD11B2, NR3C1, PTGS2 | 2.98418 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PTGS1, PTGS2, TYR | 2.98356 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, AR, BCL2, CNR2, ESR1, GSK3B, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, XDH | 2.97673 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC | 2.96079 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.93661 |
[BP] GO:0007208 | None | HTR2A, HTR2C | 2.93551 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CSNK2A1, FLT3, GSK3B, HTR2B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC | 2.9268 |
[BP] GO:0032845 | None | ADORA1, BCL2, HTR2A, HTR2B, HTR2C, SRC | 2.91469 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, APP, CNR1, CNR2, CYP19A1, DHFR, ESR1, FABP4, GSK3B, IDO1, IGF1R, MET, MMP12, MMP2, PTGS2, SRC, XDH | 2.91311 |
[BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 2.86034 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.85428 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, ESR1, GSK3B, IGF1R, KDR, MET, MMP1, MMP9, SRC | 2.85428 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.85428 |
[BP] GO:0051967 | None | ADORA1, HTR1B, HTR2A | 2.85428 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, HTR1D, IGF1R, KDR, MET, MMP9, PTGS2, SRC | 2.8443 |
[BP] GO:0008217 | None | ADORA1, AR, CNR1, HSD11B2, PTGS1, PTGS2 | 2.8443 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, APP, AR, AURKB, BCL2, ESR1, FABP3, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PTGS2, RORC, SRC, XDH | 2.83239 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, ESR1, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PTGS2, RORC, SRC, XDH | 2.81566 |
[BP] GO:0050999 | None | CNR1, CNR2, DHFR, HTR2B | 2.78773 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC | 2.77816 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, DHFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC | 2.75353 |
[BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 2.72454 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, XDH | 2.71715 |
[BP] GO:0007610 | None | APP, BCL2, CNR1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IDO1, PTGS2 | 2.71243 |
[BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.69953 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.69953 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.69953 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | AR, ESR1, NR3C1, NR3C2, PGR, RORC | 2.69742 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, SRC, TYR | 2.69628 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, HTR2A, HTR2B, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC | 2.68698 |
[BP] GO:0006954 | inflammatory response | ADORA1, ADORA3, ALOX15, AXL, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 2.6759 |
[BP] GO:0022900 | electron transport chain | AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH | 2.67339 |
[BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB | 2.66885 |
[BP] GO:0006939 | None | HTR1D, HTR2A, HTR2B, HTR7 | 2.66709 |
[BP] GO:0048609 | multicellular organismal reproductive process | AKR1B1, APP, AR, AXL, CNR1, CYP1A1, ESR1, PGR, PTGS2, SRC | 2.66373 |
[BP] GO:0044283 | None | AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 | 2.65265 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PTGS1, PTGS2, TYR | 2.60468 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, CNR1, CYP19A1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SRC | 2.60338 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, GSK3B, KDR, PIK3CB, SRC | 2.55823 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APP, AR, AURKB, BCL2, CNR1, CSNK2A1, DHFR, ESR1, FABP4, GSK3B, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC, XDH | 2.55387 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC | 2.54943 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, GSK3B, HSD11B2, IGF1R, PTGS2, SRC | 2.54737 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.54737 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PIM1, PTGS1, PTGS2, TYR | 2.53919 |
[BP] GO:0060748 | None | AR, PGR | 2.53919 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.53919 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC | 2.52825 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 2.51914 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PTGS2, SRC | 2.5093 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.50632 |
[BP] GO:0033555 | multicellular organismal response to stress | BCL2, HTR1A, HTR2C, IDO1 | 2.49511 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, APP, AR, BCL2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 2.49222 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, AXL, BCL2, CYP1B1, SRC | 2.48479 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, MMP9, SRC | 2.48479 |
[BP] GO:1901654 | None | AKR1B1, AR, CA9, CSNK2A1, NR3C1, SRC | 2.48479 |
[BP] GO:0006952 | defense response | ADORA1, ADORA3, ALOX15, APP, AXL, BCL2, CNR2, HTR1A, HTR2C, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC | 2.47621 |
[BP] GO:0009607 | response to biotic stimulus | ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, GSK3B, IDO1, MMP12, PTGS2, SRC | 2.47552 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR | 2.47552 |
[BP] GO:0032768 | None | CNR1, CNR2, DHFR, HTR2B | 2.47505 |
[BP] GO:0046394 | None | ALOX15, ALOX5, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 | 2.45289 |
[BP] GO:0016053 | None | ALOX15, ALOX5, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 | 2.44581 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PTGS2, SRC | 2.44581 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, XDH | 2.43897 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESR1, GSK3B, HTR2A, HTR2B, HTR2C, IDO1, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SRC, XDH | 2.43669 |
[BP] GO:0048608 | reproductive structure development | AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC | 2.42301 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.42301 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, PGR, PTGS2, SRC | 2.40355 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.40355 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.40355 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.40355 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, MMP2, MMP9 | 2.40044 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, SRC | 2.39148 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, GSK3B, KDR, PIK3CB, SRC | 2.38198 |
[BP] GO:0051046 | None | ACHE, ADORA1, CNR1, CYP19A1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SRC | 2.37376 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.37189 |
[BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, XDH | 2.36638 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX15, AR, BCL2, CNR1, CNR2, CYP19A1, ESR1, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, XDH | 2.35366 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9 | 2.35177 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, HTR2A, MET, PIK3CA | 2.33981 |
[BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, XDH | 2.33619 |
[BP] GO:0090407 | organophosphate biosynthetic process | ACHE, ALOX15, CSNK2A1, DHFR, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2 | 2.33021 |
[BP] GO:0002009 | morphogenesis of an epithelium | AR, BCL2, CA2, CA9, ESR1, MET, SRC | 2.32627 |
[BP] GO:0051051 | negative regulation of transport | ADORA1, APP, BCL2, CNR1, GSK3B, HTR1B, HTR2A, MMP9, PTGS2 | 2.3194 |
[BP] GO:2000209 | regulation of anoikis | BCL2, PIK3CA, SRC | 2.30143 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.30143 |
[BP] GO:0038171 | None | CNR1, CNR2 | 2.30143 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.30143 |
[BP] GO:0014827 | None | HTR1D, HTR2B | 2.30143 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, PTGS2 | 2.30104 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, PTGS2 | 2.29729 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC | 2.28074 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PTGS2, SRC | 2.25481 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.25481 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, HTR2A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH | 2.24967 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, GSK3B, HTR1B, IGF1R, MMP2, PTGS2, SRC | 2.24967 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PTGS2, SRC | 2.24388 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.24388 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS2, RORC, SRC, XDH | 2.24089 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, XDH | 2.24028 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, ESR1, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, SRC | 2.24002 |
[BP] GO:0006352 | DNA-templated transcription, initiation | AR, ESR1, NR3C1, NR3C2, PGR, RORC | 2.21062 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, MMP2, MMP9, PTGS2 | 2.20179 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, BCL2, CA12, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB | 2.19973 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, FABP3, FABP4, MET, PIK3CA, PIK3CB | 2.19312 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, SRC, TYR | 2.18693 |
[BP] GO:0002683 | negative regulation of immune system process | ADORA1, ALOX15, AXL, CNR1, CNR2, CYP19A1, IDO1, MMP12 | 2.18076 |
[BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC | 2.17821 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, KDR, MET, MMP12, PTGS2 | 2.16276 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, IDO1 | 2.15727 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, MET, PIK3CA, PIK3CB, SRC, XDH | 2.15294 |
[BP] GO:0055082 | cellular chemical homeostasis | APP, BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB | 2.14933 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 | 2.14933 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, MMP12, MMP2, PTGS2, SRC | 2.14933 |
[BP] GO:0030198 | extracellular matrix organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 | 2.12884 |
[BP] GO:0009605 | response to external stimulus | ADORA1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, HSD11B2, HTR2A, IDO1, MMP12, PTGS2, SRC, TYR | 2.12884 |
[BP] GO:1904646 | cellular response to amyloid-beta | APP, GSK3B, IGF1R | 2.12655 |
[BP] GO:0043062 | extracellular structure organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 | 2.12258 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, APP, AR, AURKB, BCL2, DHFR, ESR1, FLT3, GSK3B, HTR2A, HTR2B, MET, MMP9, PIK3CA, PIK3CB, SRC, XDH | 2.12086 |
[BP] GO:0010507 | negative regulation of autophagy | BCL2, HTR2B, MET, PIK3CA | 2.12086 |
[BP] GO:0071502 | None | HTR1B, HTR2B | 2.11999 |
[BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, XDH | 2.11768 |
[BP] GO:0031099 | regeneration | AXL, BCL2, CSNK2A1, DHFR, FLT3 | 2.10188 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AR, AXL, BCL2, CBR1, CYP1A1, ESR1, FABP4, FLT3, FUT7, GSK3B, HTR2B, KDR, MET, MMP2, MMP9, PGR, PTGS2, RORC, SRC | 2.10045 |
[BP] GO:0014059 | None | CNR1, HTR1B, HTR2A | 2.08788 |
[BP] GO:0044243 | multicellular organismal catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.08095 |
[BP] GO:0043207 | response to external biotic stimulus | ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, PTGS2, SRC | 2.06445 |
[BP] GO:0071383 | None | AR, FLT3, NR3C1, SRC | 2.06032 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC | 2.05811 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, HTR2A, HTR2C, IDO1, KDR, PIM1, PTGS2, SRC | 2.05811 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, GSK3B, HTR1B, IGF1R, MMP2, PTGS2, SRC | 2.05193 |
[BP] GO:0090087 | None | ACHE, ADORA1, APP, CA2, CNR1, GSK3B, HTR2B, HTR2C, MMP12, PTGS2, SRC | 2.05193 |
[BP] GO:0006636 | unsaturated fatty acid biosynthetic process | ALOX15, PTGS1, PTGS2 | 2.05193 |
[BP] GO:0033280 | response to vitamin D | ALPL, PTGS2, TYR | 2.05193 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, AR, BCL2, CSNK2A1, DHFR, ESR1, FABP4, FLT3, GSK3B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH | 2.03118 |
[BP] GO:0031334 | positive regulation of protein complex assembly | ALOX15, ESR1, GSK3B, MET, MMP1, SRC | 2.03118 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, GSK3B, HTR2B, MMP12, PTGS2, SRC | 2.02904 |
[BP] GO:0051952 | None | ADORA1, CNR1, HTR1B, HTR2A | 2.02904 |
[BP] GO:0022602 | ovulation cycle process | BCL2, ESR1, PGR, SRC | 2.02904 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, PIK3CB, PTGS2 | 2.02522 |
[BP] GO:0002209 | None | BCL2, HTR1A, HTR2C | 2.01853 |
[BP] GO:0001662 | None | BCL2, HTR1A, HTR2C | 2.01853 |
[BP] GO:1904645 | response to amyloid-beta | APP, GSK3B, IGF1R | 2.01853 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TYR | 6.16799 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, CA4, CNR1, CNR2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 5.81916 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, ESR1, FLT3, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, SRC | 5.5462 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, APP, AXL, CNR1, CNR2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 5.46736 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, NR3C2, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, TYR | 4.53006 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, CNR1, CNR2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTGS2, SRC | 4.40476 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AURKB, BCL2, CA2, CA4, CA7, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR4, HTR5A, IDO1, KDR, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TYR, XDH | 2.03118 |
[MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.0901 |
[MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.0901 |
[MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 16.9018 |
[MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 16.9018 |
[MF] GO:0099528 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.6671 |
[MF] GO:0008227 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 12.7388 |
[MF] GO:0043167 | ion binding | ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, TYR, XDH | 12.6958 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, APP, AR, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, RORC, TYR, XDH | 11.5979 |
[MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 11.4185 |
[MF] GO:0070405 | ammonium ion binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 9.92487 |
[MF] GO:0030594 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 9.70611 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AR, AXL, CNR1, CNR2, ESR1, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, RORC | 9.18605 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH | 9.1308 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PTGS1, PTGS2, RORC, TYR, XDH | 8.38709 |
[MF] GO:0004089 | carbonate dehydratase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 8.20896 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AR, AXL, CNR1, CNR2, ESR1, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, RORC | 8.17991 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AR, AXL, CNR1, CNR2, ESR1, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, RORC | 7.8967 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AR, AXL, CNR1, CNR2, ESR1, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, RORC | 7.30311 |
[MF] GO:0005496 | steroid binding | AR, ESR1, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC | 6.48853 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TYR, XDH | 6.20689 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC | 5.95294 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 5.5462 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET | 5.5462 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B2, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, SRC, XDH | 5.40419 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS1, PTGS2, SRC | 5.3323 |
[MF] GO:0008270 | zinc ion binding | AR, CA12, CA2, CA4, CA7, CA9, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, RORC | 5.24743 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 5.14678 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS1, PTGS2, SRC | 5.10161 |
[MF] GO:0016836 | hydro-lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 5.02169 |
[MF] GO:0003707 | steroid hormone receptor activity | AR, ESR1, NR3C1, NR3C2, PGR, RORC | 4.85923 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.40289 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 4.33267 |
[MF] GO:1901363 | heterocyclic compound binding | ADORA1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FLT3, GSK3B, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP12, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, XDH | 4.25774 |
[MF] GO:0097159 | organic cyclic compound binding | ADORA1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FLT3, GSK3B, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP12, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, RORC, SRC, XDH | 4.20779 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CNR1, CNR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 4.20779 |
[MF] GO:0042562 | hormone binding | ACHE, AR, HSD17B1, IGF1R, NQO2, NR3C1 | 4.04646 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.76115 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR | 3.72325 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 3.64867 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.57222 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.57222 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH | 3.52025 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.52025 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.52025 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.46657 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.41373 |
[MF] GO:0008289 | lipid binding | ALOX15, AR, AXL, ESR1, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC | 3.26034 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, IDO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PTGS1, PTGS2, RORC, TYR, XDH | 3.24229 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, PIK3CA, PIK3CB | 3.14119 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.0283 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.93551 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.93551 |
[MF] GO:0071886 | None | HTR2A, HTR2C | 2.93551 |
[MF] GO:0051213 | dioxygenase activity | ALOX15, ALOX5, IDO1, PTGS1, PTGS2 | 2.79814 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.75353 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIM1, SRC | 2.7427 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC | 2.72054 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.70083 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | AR, ESR1, PGR, RORC | 2.63754 |
[MF] GO:0004879 | nuclear receptor activity | AR, ESR1, PGR, RORC | 2.63754 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.53919 |
[MF] GO:0004949 | None | CNR1, CNR2 | 2.53919 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.45289 |
[MF] GO:0016829 | lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 2.42301 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC | 2.42301 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Serotonergic synapse_Homo sapiens_hsa04726 | APP, HTR1E, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 19.0477 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | HTR1E, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, NR3C1, HTR5A, HTR4, HTR6, HTR7, CNR2, CNR1, ADORA3, ADORA1 | 12.9435 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 9.4458 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 9.1245 |
Pathways in cancer_Homo sapiens_hsa05200 | AR, GSK3B, PIK3CA, FLT3, MMP1, MMP2, BCL2, PIK3CB, PTGS2, MMP9, MET, IGF1R | 6.5217 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, PTGS2, TYR, CYP19A1, PTGS1, DHFR, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH, IDO1 | 6.2368 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PIK3CB, MMP9, MET, ESR1, IGF1R | 6.2133 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HTR6, PIK3CA, HTR1E, HTR1D, ADORA1, HTR1A, HTR1B, PIK3CB, HTR4 | 6.2368 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA2, CA4, CA7, CA9, CA14 | 9.1745 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, ADORA1, PIK3CB, PTGS2, PTGS1 | 6.2 |
Focal adhesion_Homo sapiens_hsa04510 | GSK3B, PIK3CA, SRC, KDR, BCL2, PIK3CB, MET, IGF1R | 5.1838 |
Prostate cancer_Homo sapiens_hsa05215 | AR, GSK3B, PIK3CA, BCL2, PIK3CB, IGF1R | 5.1006 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, HTR2B, HTR2C, PIK3CB, HTR2A | 4.8894 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1 | 4.8894 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 5.2397 |
Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6, HTR7, HTR2B, HTR2C, HTR2A, HTR5A, HTR4 | 4.5761 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PIK3CB, PTGS2 | 4.6594 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, PTGS2, PTGS1 | 4.6505 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, CNR1, KDR, PIK3CB, MET, IGF1R | 4.1896 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | GSK3B, PIK3CA, SRC, PIK3CB, ESR1 | 4.3756 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | PIK3CA, MMP2, BCL2, PIM1, PIK3CB | 3.776 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1 | 4.3683 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIK3CA, BCL2, PIM1, CYP1B1, PTGS2, MMP9, MET | 3.3954 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | GSK3B, PIK3CA, SRC, PIK3CB, ESR1 | 3.4852 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, BCL2, ADORA1, PIK3CB | 3.4661 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.5616 |
Ras signaling pathway_Homo sapiens_hsa04014 | HTR7, PIK3CA, KDR, PIK3CB, MET, IGF1R | 3.2093 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | GSK3B, PIK3CA, KDR, BCL2, PIK3CB, MET, IGF1R | 3.1268 |
Hepatitis B_Homo sapiens_hsa05161 | PIK3CA, SRC, BCL2, PIK3CB, MMP9 | 3.1812 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, PIK3CA, PIK3CB, NR3C2 | 4.1499 |
Colorectal cancer_Homo sapiens_hsa05210 | GSK3B, PIK3CA, BCL2, PIK3CB | 3.4648 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1, IDO1 | 4.1246 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 4.0996 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, IGF1R | 3.2769 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET | 3.3615 |
Adherens junction_Homo sapiens_hsa04520 | CSNK2A1, SRC, MET, IGF1R | 3.2332 |
Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B | 3.0997 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PGR, PIK3CB, IGF1R | 2.8658 |
ErbB signaling pathway_Homo sapiens_hsa04012 | GSK3B, PIK3CA, SRC, PIK3CB | 3.0428 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | GSK3B, CSNK2A1, PIK3CA, BCL2, PIK3CB | 2.6413 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 3.1812 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, BCL2, PIK3CB | 2.6904 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, BCL2, PIK3CB, PTGS2 | 3.0513 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.6955 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, BCL2, PIK3CB, IGF1R | 2.7937 |
Gap junction_Homo sapiens_hsa04540 | SRC, HTR2B, HTR2C, HTR2A | 3.0342 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB | 2.618 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.5897 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | GSK3B, PIK3CA, BCL2, PIK3CB | 2.6082 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PIK3CB, MMP9 | 2.618 |
Measles_Homo sapiens_hsa05162 | GSK3B, CSNK2A1, PIK3CA, PIK3CB | 2.4311 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | GSK3B, PIK3CA, PIK3CB, IGF1R | 2.3856 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, PIK3CB | 2.2529 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PIK3CB, PTGS2 | 2.2529 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, ADORA1, PIK3CB | 2.173 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 2.0699 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | GSK3B, PIK3CA, SRC, PIK3CB | 2.0183 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | GSK3B, PIK3CA, PIK3CB | 2.2681 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PIK3CB, IGF1R | 2.3856 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.6242 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, PIK3CB, IGF1R | 2.0117 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, PIK3CB, IGF1R | 2.3946 |
Insulin resistance_Homo sapiens_hsa04931 | GSK3B, PIK3CA, PIK3CB | 1.8639 |
Oocyte meiosis_Homo sapiens_hsa04114 | AR, PGR, IGF1R | 1.7319 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | GSK3B, PIK3CA, PIK3CB | 1.9144 |
FoxO signaling pathway_Homo sapiens_hsa04068 | PIK3CA, PIK3CB, IGF1R | 1.6625 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 2.0183 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, PIK3CB, IGF1R | 1.7279 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.6242 |
Endometrial cancer_Homo sapiens_hsa05213 | GSK3B, PIK3CA, PIK3CB | 2.6155 |
Hepatitis C_Homo sapiens_hsa05160 | GSK3B, PIK3CA, PIK3CB | 1.6625 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.3791 |
Insulin signaling pathway_Homo sapiens_hsa04910 | GSK3B, PIK3CA, PIK3CB | 1.6242 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | GSK3B, PIK3CA, PIK3CB | 1.547 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PIK3CB | 1.565 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3198 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3325 |
Influenza A_Homo sapiens_hsa05164 | GSK3B, PIK3CA, PIK3CB | 1.4145 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.3425 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 1.2568 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB | 1.2146 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1 | 2.331 |
Hippo signaling pathway_Homo sapiens_hsa04390 | GSK3B | 0.3718 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 1.0355 |
HTLV-I infection_Homo sapiens_hsa05166 | GSK3B, PIK3CA, PIK3CB | 1.0591 |
Cell cycle_Homo sapiens_hsa04110 | GSK3B | 0.437 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GSK3B | 0.4263 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.9431 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.8013 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PIK3CB | 0.961 |
Wnt signaling pathway_Homo sapiens_hsa04310 | GSK3B, CSNK2A1 | 0.9348 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.9735 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, PIK3CB | 0.9322 |
Alzheimer's disease_Homo sapiens_hsa05010 | GSK3B, APP | 0.8386 |
Axon guidance_Homo sapiens_hsa04360 | GSK3B, MET | 0.9987 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5262 |
Melanogenesis_Homo sapiens_hsa04916 | GSK3B, TYR | 1.1492 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 1.1201 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.5255 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB | 1.1492 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PIK3CB | 1.1492 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PIK3CB | 1.1922 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.5391 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PIK3CB | 1.1556 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.2048 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | PIK3CA, PIK3CB | 1.1307 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.5402 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.5423 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.5423 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | CNR1, PTGS2 | 1.1492 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.5412 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5578 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.6002 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5981 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | PIK3CA, PIK3CB | 1.3665 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.6075 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2 | 0.6153 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PIK3CB | 1.4145 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6351 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.3844 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.6351 |
Pancreatic cancer_Homo sapiens_hsa05212 | PIK3CA, PIK3CB | 1.4245 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.6351 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.6562 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.4145 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.432 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PIK3CB | 1.4924 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PIK3CB | 1.539 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.5011 |
Basal cell carcinoma_Homo sapiens_hsa05217 | GSK3B | 0.6872 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.7135 |
Malaria_Homo sapiens_hsa05144 | MET | 0.7226 |
Hedgehog signaling pathway_Homo sapiens_hsa04340 | GSK3B | 0.7181 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.7359 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, PIK3CB | 1.6349 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.672 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.7409 |
African trypanosomiasis_Homo sapiens_hsa05143 | IDO1 | 0.841 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.841 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8834 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.9731 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.9245 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.8422 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.9961 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.9374 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.8931 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.9322 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.1628 |
One carbon pool by folate_Homo sapiens_hsa00670 | DHFR | 1.0275 |
Folate biosynthesis_Homo sapiens_hsa00790 | DHFR, ALPL | 2.5161 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.2606 |